Human papillomavirus molecular biology and pathogenesis

Journal of the European Academy of Dermatology and Venereology

Volumn 16, Issue 3, 2002, Pages 231-240

  Sanclemente, G ^a   Gill, D K ^b  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Cytokines; Epidemiology; Human papillomavirus; Keratinocytes; Langerhans cells; Pathogenesis

Indexed keywords

CYTOKINE;

CANCER INCIDENCE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; IMMUNOCOMPETENT CELL; INFECTION RATE; KERATINOCYTE; MALIGNANT TRANSFORMATION; MOLECULAR BIOLOGY; NONHUMAN; PERSISTENT VIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; REMISSION; REVIEW; SEXUALLY TRANSMITTED DISEASE; SKIN CANCER; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS STRAIN; WART VIRUS; HUMAN; IMMUNOLOGY; PAPILLOMA VIRUS; PHYSIOLOGY;

HUMAN; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS, HUMAN; SUPPORT, NON-U.S. GOV'T; HUMANS; PAPILLOMAVIRIDAE;

EID: 0035996145     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1473-2165.2002.00419.x     Document Type: Review

References (110)

1. Virus taxonomy
2. Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types
3. The structure of viruses of the papillomapolyoma type III. structure of rabbit papillomavirus
4. Structure of viruses of the papilloma-polyoma type: Human wart viruses
5. Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction
6. Human papillomavirus type-16 sequence
7. Molecular biology of HPV and mechanisms of keratinocyte transformation
8. Papillomaviruses
9. Human papillomavirus and human disease
10. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis
11. Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals
12. Human papillomavirus in human cancer
13. Human papillomavirus type 16 DNA periungual squamous cell carcinoma
14. Bowen's disease of the nail bed and periungual area
15. The role of human papillomavirus in skin cancer-current status
16. Human papillomavirus in penile squamous cell lesions: A comparison of an isotopic RNA and two commercial nonisotopic DNA in situ hybridization methods
17. Identification of the alpha-6-integrin as a candidate receptor for papillomaviruses
18. Human papillomavirus infection requires cell surface heparan sulfate
19. Papillomavirus DNA replication
20. Characterisation of Skn-1a/i POU domain factors and linkage to papillomavirus gene expression
21. Simplifying the molecular mechanisms of human papillomavirus
22. The role of human papillomaviruses in the pathogenesis and histologic classification of precancerous lesions of the cervix
23. Papillomavirinae: The viruses and their replication
24. Human papillomavirus infection
25. Immunology of human warts
26. Warts and HPV-related squamous cell tumors of the skin
27. Infection of the oral mucosa with defined types of human papillomaviruses
28. Viruses in cancers of the head and neck
29. DNA typing of genital warts and diagnosis of sexual abuse in children
30. Prevalence and expression of human papillomavirus in tonsillar carcinoma indicates a possible viral etiology
31. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
32. Prevalence of HPV in cervical cancer - A worldwide perspective
33. Human papillomavirus infection and anal carcinoma. Retrospective analysis by in situ hybridization and the polymerase chain reaction
34. High-grade dysplasia in genital warts from two patients infected with the human immunodeficiency virus
35. History of genital warts in 10,838 women 20-29 years of age from the general population. Risk factors and association with Papanicolaou smear history
36. Cervical intraepithelial neoplasia, anogenital cancer, and other cancer types in women after hospitalisation for condylomata acuminata
37. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers
38. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients
39. Verrucous carcinoma of the skin and mucosa
40. The impact of the human immunodeficiency virus on the human papillomavirus epidemic
41. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: Influence of HIV infection, immunosuppression and human papillomavirus infection
42. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals
43. Epidermodysplasia verruciformis as a model for HPV-related oncogenesis. Reference of epidermodisplasia verruciformis
44. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumors
45. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors
46. Symptomatic genital papillomavirus infection in a community - Incidence and clinical picture
47. Epidemiology of genital human papillomavirus infection
48. Epidemiology of human papilloma virus infections and genital neoplasia
49. Risk factors associated with cervical human papillomavirus infection: A case control study
50. Risk factors for condyloma acuminatum in women
51. Low-risk human papillomavirus types 6 and 11 associated with carcinomas of the genital and upper aero-digestive tract
52. Anal human papillomavirus infection in heterosexuals with genital warts: Prevalence and relation with sexual behaviour
53. Genital HPV infection not a local but a regional infection: Experience from a female teenage group
54. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women
55. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer
56. HLA antigens and cervical carcinoma
57. HLA antigens and cervical carcinoma
58. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: Results from a case control study conducted in the United States
59. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women
60. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women
61. Is p53 polymorphism maintained by natural selection?
62. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer
63. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection
64. Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53
65. Differences in cervical cancer mortality among black and white women
66. HPV DNA positivity and natural killer cell activity in the clinical outcome of mild cervical dysplasia: Integration between virus and immune system
67. Mucosal immunity to human papillomavirus in the female reproductive tract
68. Immunoglobulin G antibodies in human vaginal secretions after parental vaccination
69. Developing HPV virus-like particle vaccines to prevent cervical cancer: A progress report
70. Replication of human papillomaviruses in cell culture
71. Immunology taught by viruses
72. Papillomavirus-like particles
73. Skin-associated lymphoid tissues (SALT): Origins and functions
74. The skin immune system: Its cellular constituents and their interactions
75. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin
76. Antigen presenting capacity in normal human dermis is mainly subserved by CD1a+ cells
77. The Langerhans Cell
78. Anatomical mapping of epidermal Langerhans cell densities in adults
79. Precursors of Langerhans cells
80. Keratinocytes as initiators of inflammation
81. Direct and indirect control of T-cell activation by keratinocytes
82. Role of cytokines in epidermal Langerhans cell migration
83. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines
84. Cytokine networks in the skin
85. Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN-γ
86. The role of the immune system in anogenital human papillomavirus
87. The keratinocyte
88. IL-12 is expressed and released by human keratinocytes and epidermoid cell lines
89. Effects of immunomodulatory cytokines on the presentation of tumor-associated antigens by epidermal Langerhans cells
90. Dendritic cells in the epidermis and the lymph nodes - A review
91. Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation
92. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay
93. Cross-presentation, dendritic cells, tolerance and immunity
94. Langerhans cells in human cervical epithelium: Effects of wart virus infection and intraepithelial neoplasia
95. Langerhans cells in human warts
96. Tissue effects of and host response to human papillomavirus infection
97. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium
98. Potential strategies utilised by papillomavirus to evade host immunity
99. Langerhans cells in molluscum contagiosum, verruca vulgaris, plantar wart, and condyloma acuminatum
100. Epidermal Langerhans cells, dermal dendritic cells, and keratinocytes in viral lesions of skin and mucous membranes: An immunohistochemical study
101. Cellular subsets and epithelial ICAM-1 and HLA-DR expression in human papillomavirus infection of the vulva
102. Skin-associated lymphoid tissue in human immunodeficiency virus-1, human papillomavirus, and herpes simplex virus infections
103. Stimulation of local cytokine and cell mediated immune responses in human papillomavirus (HPV) patients receiving Imiquimod
104. HPV infection and its effects on the expression of cytokines and skin Langerhans cells
105. Immunology of papillomavirus infection
106. Immunological events in regressing genital warts
107. Autocrine growth limitation of human papillomavirus type 16-harboring keratinocytes by constitutively released tumor necrosis factor-α
108. Interferon response depends on viral transcription in human papillomavirus-containing lesions